This country profile provides an overview of Botswana’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 2/100
Overall rank: 37th

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
29%
Trachoma
N/A
69,000 people received treatment in Botswana in 2016 193,000 people in need did not receive treatment in Botswana in 2016

Botswana recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the good soil-transmitted helminths (STH) preventive chemotherapy (PC) coverage achieved, implement PC for schistosomiasis alongside STH, at least for school-aged children.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely date to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

Botswana does not require mass treatment for lymphatic filariasis.

Onchocerciasis

Botswana does not require mass treatment for onchocerciasis.

Schistosomiasis

Treatment coverage remained the same at 0% in 2015 and 2016.

School-aged children needing treatment
151,000
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

⬆️ Treatment coverage increased from 0% in 2015 to 29% in 2016.

Pre-sch and school-aged children needing treatment
236,000
Pre-school and school-aged children receiving treatment
69,000

Trachoma

Botswana does not require mass treatment for trachoma.